IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.507
EU - Europa 10.067
AS - Asia 4.186
AF - Africa 30
SA - Sud America 27
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 20
Totale 32.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.455
PL - Polonia 3.884
CN - Cina 2.613
UA - Ucraina 2.067
DE - Germania 1.206
IT - Italia 936
HK - Hong Kong 655
FI - Finlandia 544
GB - Regno Unito 457
SG - Singapore 370
IE - Irlanda 362
IN - India 204
VN - Vietnam 188
FR - Francia 186
CZ - Repubblica Ceca 93
RU - Federazione Russa 77
SE - Svezia 76
ES - Italia 59
TR - Turchia 43
CA - Canada 41
BE - Belgio 38
IR - Iran 33
NL - Olanda 30
AU - Australia 19
EU - Europa 19
MU - Mauritius 16
JP - Giappone 13
KR - Corea 9
MA - Marocco 9
CL - Cile 8
PH - Filippine 8
CH - Svizzera 7
CU - Cuba 7
RO - Romania 7
TW - Taiwan 7
AR - Argentina 5
IL - Israele 5
PE - Perù 5
BD - Bangladesh 4
BR - Brasile 4
LK - Sri Lanka 4
PK - Pakistan 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
EE - Estonia 2
EG - Egitto 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MX - Messico 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
PA - Panama 1
SC - Seychelles 1
SL - Sierra Leone 1
SM - San Marino 1
TH - Thailandia 1
Totale 32.859
Salva come PNG Salva come JPEG
Città #
Warsaw 3.883
Fairfield 3.026
Woodbridge 2.187
Jacksonville 1.579
Houston 1.481
Ashburn 1.463
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.076
Wilmington 1.059
Chandler 797
Princeton 669
Hong Kong 647
Nanjing 579
Beijing 481
Brescia 363
Dublin 358
Dearborn 336
New York 303
Helsinki 266
Singapore 206
Dong Ket 181
Nanchang 180
Shenyang 147
Des Moines 144
Hebei 144
Jinan 140
San Diego 130
Changsha 124
Shanghai 114
Jiaxing 101
Lancaster 100
Tianjin 93
Milan 81
Boardman 77
Kunming 70
Brno 64
Los Angeles 64
London 61
San Mateo 61
Hangzhou 60
Madrid 54
San Francisco 52
Haikou 48
Verona 48
Ningbo 43
Augusta 40
Lanzhou 39
Munich 38
Rome 37
Zhengzhou 36
Kocaeli 35
Leawood 33
Brussels 32
Phoenix 32
Washington 31
Guangzhou 28
Taizhou 28
Toronto 26
Fuzhou 25
Kilburn 25
Ardabil 24
Norwalk 24
Olomouc 24
Changchun 23
Monmouth Junction 23
Hefei 21
Taiyuan 19
Redwood City 18
Nürnberg 14
Orange 14
Amsterdam 12
Napoli 11
Padova 11
Pune 11
Gunzenhausen 10
Tokyo 10
Chicago 9
Falls Church 9
Ottawa 8
Wandsworth 8
Chiswick 7
Indiana 7
Ivry-sur-seine 7
La Habana 7
Melbourne 7
Romola 7
Southwark 7
Boston 6
Canberra 6
Dronten 6
Markham 6
Modena 6
Rabat 6
Santa Clara 6
Lima 5
Mumbai 5
New Bedfont 5
New Delhi 5
Sydney 5
Totale 26.396
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 277
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 267
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 245
The nanostructured secretome 241
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 237
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 232
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 229
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 228
Claudin3 is localized outside the tight junctions in human carcinomas 228
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 226
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 226
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 224
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 223
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 219
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 219
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 219
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 216
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 214
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 214
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 213
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 211
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 211
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 210
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 207
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 206
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 206
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 204
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 202
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 201
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 199
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 198
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 198
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 197
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 192
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 189
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 180
Zebrafish disease models in hematology: Highlights on biological and translational impact 171
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 165
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 161
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 160
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 158
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 156
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 154
Long pentraxin-3 follows and modulates bladder cancer progression 152
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 151
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 151
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 147
The zebrafish/tumor xenograft angiogenesis assay. 147
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 147
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 146
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 143
Anti-angiogenic activity of the purine analog 6-thioguanine. 143
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 142
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 138
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 138
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 138
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 138
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 137
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 136
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 136
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 132
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 130
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 129
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 126
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 126
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 125
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 124
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 124
Heparin octasaccharides inhibit angiogenesis in vivo. 123
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 122
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 122
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 121
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 121
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 121
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 121
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 119
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 119
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 119
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 118
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 118
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 118
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 117
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 117
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 117
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 117
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 115
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 115
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 114
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 114
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 114
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 113
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 112
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 112
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 112
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 111
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 111
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 111
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 111
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 110
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 110
Totale 16.094
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.214 0 0 0 1.166 669 1.174 1.128 1.067 781 1.235 455 539
2020/20216.021 181 641 232 709 324 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/2025188 86 57 40 5 0 0 0 0 0 0 0 0
Totale 33.587